Alphabet has halted a project under its biotech division Verily that aimed to create smart contact lenses for people with diabetes. The ambitious, years-long endeavor aimed to measure glucose levels in tears using on-lens sensors.
Alphabet has halted a project under its biotech division Verily that aimed to create smart contact lenses for people with diabetes. The ambitious, years-long endeavor aimed to measure glucose levels in tears using on-lens sensors.
Share this Article
Comment on this Article
Recommended
Please to comment